tirzepatide and nursing At a glance factsheet: for management of type 2 diabetes Tirzepatide and breastfeeding: New research

Whilst the medication is generally well-tolerated, certain symptoms or changes require professional evaluation to ensure safety and appropriate management

Lower dose = better exit from weight loss medications

Research shows 1 gram of arginine plus 1 gram of citrulline raises plasma arginine more than 2 grams of arginine alone

Frequently Asked Questions 1STEP Trials Program: Semaglutide 2.4mg for Obesity New England Journal of Medicine, 2021 2SURMOUNT-1: Tirzepatide for Treatment of Obesity New England Journal of Medicine, 2022 3Retatrutide Phase 2 Trial Results in Obesity New England Journal of Medicine, 2023 4Comparative Efficacy of GLP-1 Receptor Agonists: A Network Meta-Analysis The Lancet Diabetes & Endocrinology, 2024 5SELECT Trial: Semaglutide Cardiovascular Outcomes New England Journal of Medicine, 2023 Related Articles Comparison Tirzepatide vs Semaglutide: Which Weight Loss Medication Works Better

That's my argument for new research funding

Both medications are Schedule IV controlled substances due to their potential for dependence and misuse